DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Hibistat is a drug marketed by Molnlycke Hlth and is included in one NDA.
The generic ingredient in HIBISTAT is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
A generic version of HIBISTAT was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Molnlycke Hlth||HIBISTAT||chlorhexidine gluconate||SOLUTION;TOPICAL||018300-001||Approved Prior to Jan 1, 1982||OTC||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|